Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Biogen Inc., a leading biotechnology company, is headquartered in the United States, with significant operations in Cambridge, Massachusetts, where its biologics manufacturing facility is located, and a distribution centre in Somerville. Founded in 1978, Biogen has established itself as a pioneer in the development of therapies for neurological diseases, including multiple sclerosis and spinal muscular atrophy.
The company is renowned for its innovative biologics, which leverage advanced manufacturing techniques to deliver high-quality treatments. Biogen's commitment to research and development has positioned it as a key player in the biotechnology industry, with notable achievements such as the first approved treatment for spinal muscular atrophy. With a strong market presence, Biogen continues to drive advancements in patient care through its unique product offerings and dedication to scientific excellence.
No reported emissions data is available for Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville yet.
Biogen Inc., specifically its Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville, currently does not have publicly available emissions data for the most recent year. As a result, specific carbon emissions figures in kg CO2e are not provided.
The organisation is part of a corporate family that cascades emissions data and climate commitments from Thermo Fisher Scientific Inc., with a cascade level of 3. This means that any climate initiatives or targets may be influenced by the broader commitments of Thermo Fisher Scientific Inc. However, no specific reduction targets or achievements have been detailed for Biogen's facilities.
Biogen's climate commitments are aligned with industry standards, but specific initiatives or pledges, such as those under the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), are not explicitly mentioned in the available data. The absence of detailed emissions data and reduction targets suggests that further transparency may be needed to fully assess Biogen's climate impact and commitments.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Biogen Inc., Biologics Manufacturing Facility in Cambridge and Distribution Center in Somerville yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more